Clinical Mass Spectrometry Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Clinical Mass Spectrometry Market to 2027 - Global Analysis and Forecasts By Product (GAS Chromatography-Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, MALDI TOF Mass Spectrometer, Capillary Electrophoresis-Mass Spectrometry, and Ion Mobility Spectrometry-Mass Spectrometry), Application (Drug Discovery, Clinical Testing, and Proteomics), End User (Hospitals, Diagnostic Centers, and Research Laboratories) and Geography

Report Code: TIPBT00002551 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Clinical mass spectrometry is a quantitative and qualitative analytical tool for the evaluation of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical diagnostic mass spectrometers have the capability to examine a limited range of samples such as biomarkers, proteins or drug molecules at once, even in cases of low concentrations thus, making them a valuable tool for diagnostic medical laboratories.

The clinical mass spectrometry market is anticipated to grow with a significant rate in the coming years, owing to factors such as faster increase in advancements in technology of spectrometry, increased investments in R&D and advancement of healthcare technologies. Moreover, increase in developments in the emerging nations, funds provided by the government bodies offer growth opportunities in the clinical mass spectrometry market.

The "Global Clinical Mass Spectrometry Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global clinical mass spectrometry market trend. The report aims to provide an overview of global clinical mass spectrometry market with detailed market segmentation by product, application, end-user, and geography. The global clinical mass spectrometry market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the clinical mass spectrometry market.

The global clinical mass spectrometry market is segmented on the basis of product, application, and end-user. The product segment includes gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, MALDI TOF mass spectrometer, capillary electrophoresis-mass spectrometry, and ion mobility spectrometry-mass spectrometry. Based on application, the clinical mass spectrometry market is segmented as, drug discovery, clinical testing, and proteomics. Based on end user, the market is classified as, hospitals, diagnostic centers, and research laboratories.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global clinical mass spectrometry market based on product, application, and end-user. It also provides market size and forecast till 2027 for overall clinical mass spectrometry market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The clinical mass spectrometry market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to hold the maximum share of clinical mass spectrometry market, owing to the presence of major key players and strategic collaborations. However, Asia Pacific is also expected to grow at a significant growth rate owing to increased investments in R&D by various players and government bodies along with the introduction of new in-house manufacturing and R&D facilities.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key clinical mass spectrometry manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Bruker, Thermo Fisher Scientific Inc., Danaher, Agilent Technologies, PerkinElmer Inc., Shimadzu Corporation, Kore Technologies, BME Bergmann, Mass Spectrometry Instruments, and Photonics GmbH among others.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CLINICAL MASS SPECTROMETRY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Clinical Mass Spectrometry Market - By Product
3.2.2. Clinical Mass Spectrometry Market - By Application
3.2.3. Clinical Mass Spectrometry Market - By End User
3.2.4. Clinical Mass Spectrometry Market - By Region
3.2.4.1. By Country

4. CLINICAL MASS SPECTROMETRY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. CLINICAL MASS SPECTROMETRY MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
5.2. GLOBAL CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. GAS CHROMATOGRAPHY-MASS SPECTROMETRY MARKET
6.3.1. Overview
6.3.2. GAS Chromatography-Mass Spectrometry Market Revenue Forecasts and Analysis (US$ Mn)
6.4. LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY MARKET
6.4.1. Overview
6.4.2. Liquid Chromatography-Mass Spectrometry Market Revenue Forecasts and Analysis (US$ Mn)
6.5. MALDI TOF MASS SPECTROMETER MARKET
6.5.1. Overview
6.5.2. MALDI TOF Mass Spectrometer Market Revenue Forecasts and Analysis (US$ Mn)
6.6. CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRY MARKET
6.6.1. Overview
6.6.2. Capillary Electrophoresis-Mass Spectrometry Market Revenue Forecasts and Analysis (US$ Mn)
6.7. ION MOBILITY SPECTROMETRY-MASS SPECTROMETRY MARKET
6.7.1. Overview
6.7.2. Ion Mobility Spectrometry-Mass Spectrometry Market Revenue Forecasts and Analysis (US$ Mn)

7. CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. DRUG DISCOVERY MARKET
7.3.1. Overview
7.3.2. Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
7.4. CLINICAL TESTING MARKET
7.4.1. Overview
7.4.2. Clinical Testing Market Revenue Forecasts and Analysis (US$ Mn)
?
7.5. PROTEOMICS MARKET
7.5.1. Overview
7.5.2. Proteomics Market Revenue Forecasts and Analysis (US$ Mn)

8. CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.4. DIAGNOSTIC CENTERS MARKET
8.4.1. Overview
8.4.2. Diagnostic Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. RESEARCH LABORATORIES MARKET
8.5.1. Overview
8.5.2. Research Laboratories Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
9.2. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
9.7. US MARKET OVERVIEW
9.7.1. US Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. US Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3. US Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. Canada Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3. Canada Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.2. Mexico Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3. Mexico Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 -COUNTRY ANALYSIS
10.1. EUROPE CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
10.2. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
10.7. UK MARKET OVERVIEW
10.7.1. UK Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. UK Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. UK Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Germany Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Germany Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.2. France Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. France Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
11.2. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Japan Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. Japan Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. China Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. China Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. India Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. India Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. South Africa Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. South Africa Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. Saudi Arabia Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. Saudi Arabia Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. UAE Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. UAE Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET OVERVIEW
13.2. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.2. Brazil Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. Brazil Clinical Mass Spectrometry Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. CLINICAL MASS SPECTROMETRY MARKET, KEY COMPANY PROFILES
15.1. BRUKER
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. THERMO FISHER SCIENTIFIC INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
?
15.3. DANAHER
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. AGILENT TECHNOLOGIES
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. PERKINELMER INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. SHIMADZU CORPORATION
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. SWOT Analysis
15.6.5. Key Developments
?
15.7. KORE TECHNOLOGIES
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. BME BERGMANN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. MASS SPECTROMETRY INSTRUMENTS
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. PHOTONICS GMBH
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

?
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Bruker
2. Thermo Fisher Scientific Inc.
3. Danaher
4. Agilent Technologies
5. PerkinElmer Inc.
6. Shimadzu Corporation
7. Kore Technologies
8. BME Bergmann
9. Mass Spectrometry Instruments
10. Photonics GmbH

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book